Stacy W. Gray, MD

Associate Clinical Professor, Department of Medical Oncology

City of Hope

Dr. Gray received her MD from the University of Chicago Pritzker School of Medicine. She completed her residency in Internal Medicine and her fellowship in Hematology/Oncology at The University of Chicago Hospitals. While in fellowship, Dr. Gray obtained a Masters degree in Public Policy from the University of Chicago Harris School. 
After fellowship, Dr. Gray completed a post-doctoral research fellowship in cancer communication at the University of Pennsylvania. In 2008, she joined the faculty of the Dana-Farber Cancer Institute, the Brigham and Women's Hospital and Harvard Medical School where she worked as a medical oncologist and cancer outcomes researcher in the division of Population Sciences and the Lowe Center for Thoracic Oncology. In the fall of 2016, Dr. Gray moved to The City of Hope Medical Center as an Associate Professor in the Department Medical Oncology, Population Sciences, Division of Clinical Cancer Genetics. Dr. Gray currently serves as the Deputy Director of the Center for Precision Medicine and the Division Chief for Clinical Cancer Genomics at the City of Hope.

Dr. Gray’s research focuses on understanding the medical and psychosocial outcomes related to the use of genomic technologies in cancer care.  One of Dr. Gray’s goals is to understand the relationships between information dissemination, on an individual and population level, and the adoption of personalized cancer technologies. Dr. Gray also studies the clinical implementation of cancer whole-exome sequencing (WES), the "actionability" of sequence data in different populations, the integration of genomic data into the electronic health record and the social and behavioral science methods that can be used to answer emerging questions in cancer dissemination and implementation research. Dr. Gray’s overall goal is to gain a better understanding of how a variety of factors may be working to drive the use of new genomic technologies and design targeted interventions to improve the delivery of personalized cancer care. 

Thomas Slavin, MD, FACMG, DABMD

Senior Vice President of Medical Affairs for Oncology

Myriad Genetics

Dr. Slavin is Senior Vice President of Medical Affairs for Oncology at Myriad Genetics. He is a physician-scientist, triple-board-certified in clinical genetics, molecular diagnostics and pediatrics. Most recently, he served as assistant professor in the departments of Medical Oncology & Therapeutics Research and Population Sciences at City of Hope National Medical Center. Dr. Slavin graduated medical school with Alpha-Omega-Alpha-honors from the University of South Florida. He completed his residency programs at Case Western Reserve in Cleveland, Ohio; this training included a postdoctoral research year in genetic epidemiology. He has also completed graduate course work towards a Masters degree in clinical research through the University of Southern California. He is an active member of the American Association of Cancer Research, the American Society of Clinical Oncology (ASCO), the American Society of Human Genetics, the Collaborative Group of the Americas on Inherited Colorectal Cancer, and is a fellow of the American College of Medical Genetics and Genomics. He has served on National Comprehensive Cancer Network (NCCN)committees for both the genetics of and screening for colorectal cancer. He has served on three ClinGen expert working group committees for variant classification of breast, gastrointestinal and ovarian cancer predisposition genes. Focused on expanding genetics education for cancer care providers, Dr. Slavin has helped shape both ASCO University as well as City of Hope’s hereditary genomics training program. He is a well-published researcher in the field of medical genetics, including over 60 journal articles, multiple book chapters, and numerous presentations at national and international medical meetings. He has been involved in many national cancer research grants, and was a 2018 National Institutes of Health (NIH) K08-career development grant awardee.

Components visible upon registration.